ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,678,000 | -2.0% | 535,644 | -1.0% | 0.01% | 0.0% |
| Q4 2017 | $2,733,000 | -23.4% | 541,134 | -5.9% | 0.01% | -26.7% |
| Q3 2017 | $3,567,000 | +26.8% | 575,268 | -26.4% | 0.02% | +15.4% |
| Q2 2017 | $2,813,000 | +7.0% | 781,267 | -3.4% | 0.01% | +8.3% |
| Q1 2017 | $2,630,000 | +32.8% | 809,129 | +0.1% | 0.01% | +33.3% |
| Q4 2016 | $1,980,000 | -27.4% | 808,018 | +1.9% | 0.01% | -25.0% |
| Q3 2016 | $2,726,000 | -1.1% | 792,581 | +0.0% | 0.01% | 0.0% |
| Q2 2016 | $2,757,000 | -14.6% | 792,358 | +1.4% | 0.01% | -14.3% |
| Q1 2016 | $3,227,000 | -7.2% | 781,296 | 0.0% | 0.01% | -6.7% |
| Q4 2015 | $3,477,000 | -28.4% | 781,296 | -2.1% | 0.02% | -25.0% |
| Q3 2015 | $4,858,000 | – | 797,719 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |